ArticlePLoS neglected tropical diseases2025
Drivers of rabies post-exposure prophylaxis noncompletion in Cambodia, 2019 to 2022.
Article in PLoS neglected tropical diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundAchieving the "Zero by 30" goal-zero human deaths due to dog-mediated rabies by 2030-depends heavily on the timely and complete administration of post-exposure prophylaxis vaccination (PEPV) to exposed individuals. This study aims to assess trends and evaluate rabies PEPV noncompletion following the introduction of the abridged 1-week protocol, and identify its drivers in Cambodia, which bears a high rabies burden. METHODOLOGY: A retrospective analysis of patients attending the three Institut Pasteur du Cambodge (IPC) rabies prevention centers (RPCs) between 2019 and 2022 was conducted to assess exposure categories and PEPV completion. Multivariate regression was used to identify factors associated with noncompletion.
resultsAmong the 239,874 patients with a category II or III exposure requiring PEPV who attended the three IPC RPCs from 2019 to 2022, 6.4% did not complete the full three-session PEPV regimen or the two-session regimen for the previously immunized patients. Greater travel time to the RPC was strongly associated with lower attendance and completion rates. In addition, noncompletion was more common among males and working-age youth (15-29). Attendance and completion dropped sharply during Covid-19 mobility restriction periods and, conversely, rose markedly following a social media event publicizing a rabies-related death in 2019. Other factors significantly associated with PEPV noncompletion included year of PEPV administration, RPC location, species of the biting animal, health and living status, mode of attack and type of attack, and time between exposure and the first PEPV dose received.
conclusionsAlthough overall PEPV noncompletion rates were low at IPC's RPCs, this study revealed significant temporal and spatial variations. Travel time to RPC emerged as a major barrier to both RPC attendance and PEPV completion, underscoring the need to decentralize PEPV delivery to reduce access inequities. High-risk groups, particularly males and youth (15-29), would benefit from targeted communication strategies and flexible service hours. These findings can inform rabies prevention strategies in Cambodia by guiding the development of more equitable and effective PEPV delivery systems-critical to achieve the "Zero by 30" goal.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.